Eli Lilly’s $1.5 billion cash deal for Bothell-based Curevo Vaccine is the kind of validating, capital-attracting exit Puget Sound’s life sciences cluster has...
ByThe RegistryMay 28, 2026The pioneering life science REIT posts its fifth consecutive quarterly loss while accelerating asset sales to shore up balance sheet Alexandria Real Estate...
ByThe RegistryJanuary 28, 2026Quarterly loss and major asset write-downs signal ongoing challenges for pioneering life science REIT Alexandria Real Estate Equities reported its fourth consecutive quarterly...
ByThe RegistryOctober 28, 2025Markets from San Diego to Seattle show divergent fortunes as funding uncertainty and soaring vacancies reshape the sector’s real estate landscape The gleaming...
ByThe RegistryOctober 22, 2025
Signup for news and special announcements!
You have successfully joined our subscriber list.